T6687

Tris Base

99-101% dry basis, crystalline, meets USP testing specifications

Manufacturer: Sigma Aldrich

CAS Number: 77-86-1

Synonym(S): 2-Amino-2-(hydroxymethyl)-1,3-propanediol, THAM, Tris base, Tris(hydroxymethyl)aminomethane, Trometamol, Tris

Select a Size

Pack Size SKU Availability Price
100 G T6687-100-G In Stock ₹ 5,360.00
1 KG T6687-1-KG In Stock ₹ 24,950.00
5 KG T6687-5-KG In Stock ₹ 82,010.20
10 KG T6687-10-KG In Stock ₹ 1,58,218.20
25 KG T6687-25-KG In Stock ₹ 3,75,952.25

T6687 - 100 G

₹ 5,360.00

In Stock

Quantity

1

Base Price: ₹ 5,360.00

GST (18%): ₹ 964.80

Total Price: ₹ 6,324.80

product name

Tromethamine, meets USP testing specifications

Agency

meets USP testing specifications

Quality Level

200

Assay

99-101% dry basis

form

crystalline

pH

10.0-11.5 (5%)

SMILES string

NC(CO)(CO)CO

InChI

1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2

InChI key

LENZDBCJOHFCAS-UHFFFAOYSA-N

Related Products

Img

Sigma Aldrich

21685

ready-to-use solution...

Img

Sigma Aldrich

T1699

1.5 M, liquid...

Img

Sigma Aldrich

T1258

≥99.0% (titration)...

Img

Sigma Aldrich

T8691

--

Img

Sigma Aldrich

T3128

--

Img

Sigma Aldrich

S1304

meets USP testing specifications...

Img

Sigma Aldrich

C8606

meets USP testing specifications...

Img

Sigma Aldrich

F9048

98.0-102.0% dry basis, meets USP te...

Description

  • Application: Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.: This research explores the preparation and characterization of a coamorphous material of rifampicin with Tromethamine, showcasing its potential in enhancing the solubility and stability of pharmaceuticals (Queiroz et al., 2024). REKOVER study protocol: a prospective patient treatment registry of tramadol and dexKetoprofen trometamol oral fixed-dose combination (SKUDEXA) in moderate to severe acute pain in real-world setting in Asia.: This study involves the use of dexketoprofen trometamol in a fixed-dose combination with tramadol for managing moderate to severe acute pain, providing evidence of its effectiveness in real-world clinical settings (Ho et al., 2024).
  • Other Notes: Easily compare specifications for Trizma products with the Trizma specification table.

SAFETY INFORMATION

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves